Stream Bio and MIP Diagnostics Ltd. are collaborating on the development of a SARS-Cov-2 antigen reagent for assays, a lateral flow Rapid Diagnostic Test and an “ELISA” type assay for high throughput screening.

Whole pathogen quality controls to support accurate coronavirus testing are available from Randox Laboratories.

PrecisionLife is offering free use of its analytics platform and support from its data and biomedical science teams to the on-going collaborative efforts of the medical research community in the fight against the novel coronavirus.

AMSBIO offers a trio of sterilization systems suitable for a range of applications from sterilizing small laboratory instruments to sterilizing large research facilities.

Mologic Ltd has announced that it will begin manufacturing its laboratory diagnostic test for COVID-19.

The two companies will jointly develop coronavirus antigen array products for serological studies of COVID-19 and other infectious diseases.

The International Vaccine Institute (IVI) announced today that the Coalition for Epidemic Preparedness Innovations (CEPI) has granted $6.9 million funding to INOVIO (NASDAQ:INO) to work with IVI and the Korea National Institute of Health (KNIH) for a Phase 1/2 clinical trial of INOVIO's COVID-19 vaccine candidate (INO-4800) in South Korea.

Bioscience Institute are working towards a protocol for treating COVID-19 with stem cells isolated and expanded at the company’s facilities.

In response to the global COVID-19 pandemic, Beckman Coulter has announced that it is developing assays to identify IgM and IgG antibodies to SARS-CoV-2.

Care Access Research has announced it is leading a validation trial in conjunction with the FDA for a new at-home COVID-19 test developed by a private genomics lab that manufactures DNA screening kits.